Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
mean decrease » a decrease (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
mean decrease » a decrease (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
11861
-
11862
IFN-γ counter-regulates hepatic fetuin-A expression.
Published 2013“…<p><b>A</b>). <i>IFN-γ decreased fetuin-A expression levels in hepatocytes</i>. …”
-
11863
-
11864
-
11865
Id2 down regulation drives Neuro2a AD cells towards the AI phenotype.
Published 2013“…<p>(<b>A, B</b>) BrdU incorporation assay demonstrated that transfection of AD cells with Id2-siRNA reduced the rate of proliferation. …”
-
11866
Knockdown of CN-A attenuate the protein synthesis inhibition under ER stress.
Published 2010“…Note that CN is decreased by the CN-A morpholinos treatment only after ER stress (lane M-tg 6). …”
-
11867
-
11868
LTP modulates steady-state inactivation of A-type K<sup>+</sup> currents.
Published 2009“…Scale bars, 200 pA, 50 ms. The A-current available for activation at −60 mV was significantly decreased only in the neurons receiving paired stimulation 10 min after conditioning stimulation (a red arrow). …”
-
11869
-
11870
Expression of proteins associated with AD is altered by eIF4A inhibition.
Published 2013“…Significant differences (p≤0.05 by t-test) are indicated by asterisks. <b>C</b>. Secreted A-beta levels in the medium of 9×10<sup>5</sup> SH-SY5Y cells were assayed by ELISA 24 hours following treatment with 10 µM hippuristanol (+), demonstrating a modest but reproducible decrease in comparison to control cells (−). …”
-
11871
-
11872
-
11873
Table 1_Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study.docx
Published 2025“…After 12 weeks and 24 weeks of treatment, patients in all three groups showed a significant decrease in 24 h proteinuria from baseline (P < 0.05). …”
-
11874
-
11875
-
11876
-
11877
-
11878
-
11879
-
11880